Human transthyretin gene expression is markedly increased in repair Schwann cells in an in vitro model of hereditary transthyretin amyloidosis
- PMID: 36796540
- DOI: 10.1016/j.neuint.2023.105507
Human transthyretin gene expression is markedly increased in repair Schwann cells in an in vitro model of hereditary transthyretin amyloidosis
Abstract
Hereditary transthyretin (TTR) amyloidosis (ATTRv) is characterized by TTR amyloid deposition in the peripheral nervous system. It remains unknown why variant TTR preferentially deposits in the peripheral nerves and dorsal root ganglia. We previously detected low levels of TTR expression in Schwann cells and established an immortalized Schwann cell line, TgS1, derived from a mouse model of ATTRv amyloidosis expressing the variant TTR gene. In the present study, the expression of TTR and Schwann cell marker genes was investigated in TgS1 cells by quantitative RT-PCR. TTR gene expression was markedly upregulated in TgS1 cells incubated in non-growth medium-Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum. The expression levels of c-Jun, Gdnf and Sox2 were increased, while Mpz was downregulated, suggesting that TgS1 cells exhibit a repair Schwann cell-like phenotype in the non-growth medium. Western blot analysis revealed that TTR protein was produced and secreted by the TgS1 cells. Furthermore, downregulation of Hsf1 with siRNA induced TTR aggregates in the TgS1 cells. These findings indicate that TTR expression is markedly increased in repair Schwann cells, likely to promote axonal regeneration. Therefore, aged dysfunctional repair Schwann cells may cause the deposition of variant TTR aggregates in the nerves of patients with ATTRv.
Keywords: Amyloidosis; Peripheral nerve; Repair Schwann cell; Transthyretin.
Copyright © 2023 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Schwann cells contribute to neurodegeneration in transthyretin amyloidosis.J Neurochem. 2015 Jul;134(1):66-74. doi: 10.1111/jnc.13068. Epub 2015 Mar 2. J Neurochem. 2015. PMID: 25693163
-
The Expression of Chemokines Is Downregulated in a Pre-Clinical Model of TTR V30M Amyloidosis.Front Immunol. 2021 May 19;12:650269. doi: 10.3389/fimmu.2021.650269. eCollection 2021. Front Immunol. 2021. PMID: 34093538 Free PMC article.
-
Transthyretin Amyloid Neuropathy: The Schwann Cell Hypothesis.Adv Exp Med Biol. 2019;1190:371-378. doi: 10.1007/978-981-32-9636-7_24. Adv Exp Med Biol. 2019. PMID: 31760657 Review.
-
The transthyretin gene is expressed in Schwann cells of peripheral nerves.Brain Res. 2010 Aug 12;1348:222-5. doi: 10.1016/j.brainres.2010.06.017. Epub 2010 Jun 12. Brain Res. 2010. PMID: 20547140
-
Amyloid Neuropathy: From Pathophysiology to Treatment in Light-Chain Amyloidosis and Hereditary Transthyretin Amyloidosis.Ann Neurol. 2024 Sep;96(3):423-440. doi: 10.1002/ana.26965. Epub 2024 Jun 24. Ann Neurol. 2024. PMID: 38923548 Review.
Cited by
-
Immortalized Schwann cell lines as useful tools for pathogenesis-based therapeutic approaches to diabetic peripheral neuropathy.Front Endocrinol (Lausanne). 2025 Jan 21;15:1531209. doi: 10.3389/fendo.2024.1531209. eCollection 2024. Front Endocrinol (Lausanne). 2025. PMID: 39906036 Free PMC article. Review.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous